By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


SynteractHCR (Formerly Known As Synteract) 

5759 Fleet Street
Suite 100
Carlsbad  California  92008  U.S.A.
Phone: 760-268-8200 Fax: 760-929-1419


SynteractHCR is a full-service contract research organization with a successful two-decade plus track record supporting biotechnology, medical device and pharmaceutical companies in all phases of clinical development. SynteractHCR has conducted Phase I-IV studies on six continents and in more than 60 countries, offering expertise across multiple therapeutic areas and with notable depth in oncology, CNS, infectious disease, endocrinology, cardiovascular and respiratory, among other indications. With its “Shared Work – Shared Vision” philosophy and ICD+ approach, SynteractHCR provides customized services collaboratively and cost effectively, ensuring on-time delivery of quality data so clients get to decision points faster.

Key Statistics

Ownership: Subsidiary

Web Site: SynteractHCR
Employees: 350

Company News
SynteractHCR Global Nordic ePharma Day And Pediatric Drug Development Conferences Medical And Regulatory Affairs Expert Dr. Martine Dehlinger-Kremer Speaking At In April 4/13/2016 11:03:24 AM
SynteractHCR Team Participates In San Diego “Fight For Air” Climb Sponsored By The American Lung Association 3/31/2016 10:53:09 AM
SynteractHCR Increases Presence In East Coast Biotech Markets Through Presentations At OCT Southeast And Clinical Trial Collaborations Conferences 3/15/2016 10:33:13 AM
SynteractHCR Begins 2016 At U.S. And European Events Focused On Improving Clinical Trial Processes 2/4/2016 11:50:04 AM
SynteractHCR Becomes Accredited In Medidata Balance To Broaden Randomization And Trial Supply Management Capabilities 1/12/2016 2:23:50 PM
SynteractHCR To Share Insights On The New EU Clinical Trials Regulation At 2015 Partnerships In Clinical Trials Europe 11/10/2015 11:16:12 AM
SynteractHCR Appoints Vice President Of Global Clinical Operations 10/27/2015 11:31:29 AM
SynteractHCR Experts Sharing Insights On Drug Development Topics At US And European Biopharma Events During Fall 2015 9/10/2015 11:37:11 AM
SynteractHCR Enhances Technology Offerings For Clients Through Upgrades, Certifications And Additions 9/3/2015 10:57:43 AM
SynteractHCR Requalifies As Certified Member Of BVMA, The Federal Association Of CROs In Germany 8/12/2015 10:01:42 AM